TIDMAVCT

RNS Number : 3456B

Avacta Group PLC

06 January 2015

Avacta Group plc

("Avacta", the "Group" or the "Company")

Issue of Equity

Avacta Group plc (AIM: AVCT), a global provider of research reagents, consumables and equipment to the life sciences and animal care markets, today announces that 7,500,000 Ordinary Shares of 0.1p ("new Ordinary Shares") have been issued by the Company pursuant to the exercise of share options.

Application has been made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 9 January 2015.

The total number of Ordinary Shares in issue following the above issue will be 4,975,149,550 each with voting rights. No Ordinary Shares are held in Treasury.

The above figure of 4,975,149,550 shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 
 Avacta Group plc                                                            www.avacta.com 
 Alastair Smith, Chief Executive                                  Tel: +44 (0) 844 414 0452 
  Officer 
 Tim Sykes, Chief Financial 
  Officer 
                                                                  Tel: +44 (0) 20 7260 1000 
   Numis Securities Limited 
 Michael Meade / Freddie Barnfield (Nominated 
  Adviser) 
 James Black (Corporate Broking) 
                                         Tel: +44 (0) 20 7933 8780 or avacta@walbrookpr.com 
   Walbrook PR Limited 
 Mike Wort                                                         Mob: +44 (0)7900 608 002 
 Anna Dunphy                                                       Mob: +44 (0)7876 741 001

Avacta Group plc is a global provider of research reagents, consumables and equipment to the life sciences and animal care. Avacta operates through three divisions:

 
 Avacta Life Sciences          Novel non-antibody affinity reagents called 
  www.avactalifesciences.com    Affimers, with a wide range of Life Science 
                                applications in diagnostics, drug and biomarker 
                                discover and biotech research and development. 
----------------------------  ------------------------------------------------------- 
 Avacta Animal Health          Veterinary diagnostics reference laboratory 
  www.avactaanimalhealth.com    services, SensiTest, and diagnostic kits, 
                                SensiPak. 
----------------------------  ------------------------------------------------------- 
 Avacta Analytical             High throughput analysis instrument, Optim, 
  www.avactaanalytical.com      to help reduce the cost and risk of drug development. 
----------------------------  -------------------------------------------------------

Avacta joined AIM in August 2006 and is based in Wetherby, England.

This information is provided by RNS

The company news service from the London Stock Exchange

END

IOEUVVKRVAAARAR

Avacta (LSE:AVCT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Avacta Charts.
Avacta (LSE:AVCT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Avacta Charts.